Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-CS Polyclonal Antibody

Catalog #:   PHB18501 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: O75390
Overview

Catalog No.

PHB18501

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human CS (Lys103-Ala394).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

CS,Citrate synthase,mitochondrial,Citrate (Si)-synthase

Purification

Purified by antigen affinity column.

Accession

O75390

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CS antibody (PHB18501) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 35 kDa
    Observed MW: 35 kDa
References

Immune checkpoint inhibitors for advanced oesophageal cancer treated with surgery, radiotherapy or chemotherapy., PMID:40522168

GPA33-pretargeted radioimmunotherapy with mono- and bivalent DOTA-based Lu-177-labeled radiohaptens in a mouse orthotopic liver xenograft model of metastatic human colorectal cancer., PMID:40521192

Electrochemical molecularly imprinted polymer sensors in viral diagnostics: Innovations, challenges and case studies., PMID:40513291

The Intrabody Against Murine Double Minute 2 via a p53-Dependent Pathway Induces Apoptosis of Cancer Cell., PMID:40508092

Development and characterization of an innovative Flavobacterium oreochromis antigen-encapsulated hydrogel bead for enhancing oral vaccine delivery in hybrid red tilapia (Oreochromis spp.)., PMID:40505878

Thrombophilia Testing in Venous Thromboembolism., PMID:40500088

Anti-VGLUT2 autoantibodies in neurological diseases., PMID:40494504

Strong antibody reactivity to HIV-1 synthetic peptides in seropositive indigenous Warao people., PMID:40493828

T cell and autoantibody recognition of nucleus-associated islet autoantigens in individuals with type 1 diabetes., PMID:40490584

The characterization of Klebsiella pneumoniae associated with neonatal sepsis in low- and middle-income countries to inform vaccine design., PMID:40490475

Cell-free protein synthesis and vesicle systems for programmable therapeutic manufacturing and delivery., PMID:40474273

Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer., PMID:40474033

Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab-resistant HER2-positive breast cancer., PMID:40464376

Triptolide-based cleavable antibody-drug conjugates for pancreatic cancer., PMID:40460724

Computational design of therapeutic antibodies with improved developability: efficient traversal of binder landscapes and rescue of escape mutations., PMID:40458889

Programmable wide-range pH gradients for NMR titrations: application to antibody-drug conjugate linker group modifications., PMID:40452465

Fast-tracking rapid cyanotoxin detection: A novel immunoassay for emerging dihydroanatoxins., PMID:40449377

Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency., PMID:40445758

A Bioelectronic Immunosensing Platform Comprising a Gold Dendritic 3D Architecture Sandwiched between Graphene Sheets for Oral Cancer Detection., PMID:40444725

Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study., PMID:40442445

Efficacy of RTS,S/AS01E only seen in baseline parasitemic and not baseline aparasitemic Plasmodium falciparum-exposed, drug-treated Kenyan adults., PMID:40439411

A Cyclic-di-AMP Adjuvanted CPAF Protein Vaccine Is Immunogenic in Swine, but It Fails to Reduce Genital Chlamydia trachomatis Burden., PMID:40432080

Increasing the odds: antibody-mediated delivery of two distinct immunogenic T-cell epitopes with one antibody., PMID:40426019

Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function., PMID:40425544

Balancing Reactivity and Specificity: Fc-Binding O-Acyl Hydroxamate Reagents for Site-Selective Antibody Labeling at Lys248., PMID:40423997

Ultrasensitive Analysis of BRCA-1 Based on Gold Nanoparticles and Molybdenum Disulfide Electrochemical Immunosensor with Enhanced Signal Amplification., PMID:40422069

Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional Study., PMID:40418566

Digital Butterworth filter as preprocessing method for implementing Raman spectroscopy as an analytical method in downstream processing of biopharmaceuticals., PMID:40412280

Evaluation of Anti-SARS-CoV-2 IgG Responses in a Clinical Study of a Biosimilar Candidate to Denosumab Using Singlicate Analysis., PMID:40408051

Targeted Radionuclide Therapy Using a Lutetium-177 Labeled Human Anti-CD133 Antibody., PMID:40405046

Seroprevalence and Placental Transfer of Zika and Dengue Virus Antibodies in Postpartum Women in Southeast Brazil., PMID:40400258

Ultrasensitive Electrochemiluminescence Immunosensor of Procalcitonin Based on Synergistic Enhancement by Hf-MOF/g-C3N4 via Integration of Dual Luminophores, a Coreactant Accelerator, and Energy Transfer., PMID:40388807

B-cell immune repertoire sequencing in tobacco cigarette smoking, vaping, and chronic obstructive pulmonary disease in the COPDGene cohort., PMID:40386772

Sensitizing solid tumors to CAR-mediated cytotoxicity by lipid nanoparticle delivery of synthetic antigens., PMID:40379831

A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug development., PMID:40374778

Perspectives on the use of the CRISPR system in plants to improve recombinant therapeutic protein production., PMID:40373829

Therapeutic targeting of alternative pathway and C5 but not C5a protects from disease development in a preclinical model of autoimmune blistering dermatosis., PMID:40370446

A Highly Sensitive Silicon-Core Quantum Dot Fluorescent Probe for Vomitoxin Detection in Cereals., PMID:40361627

Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)., PMID:40360544

Mimicking immune complexes for efficient antibody responses., PMID:40356891

Synthetic Peptide Antibodies via a Rational Approach Based on Disulfide-Stabilized α-Helical Peptides, for the Recognition of the Intrinsically Disordered Protein NUPR1., PMID:40356443

Paraneoplastic Tumefactive Demyelination With Underlying Anaplastic Thyroid Cancer: A Case Report and Review of the Literature., PMID:40352331

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial., PMID:40349714

Multifaceted arsenal in SELEX nanomedicine., PMID:40344950

Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study., PMID:40339592

Synthesis of the Pentasaccharide Unit of the Pseudomonas aeruginosa Exopolysaccharide Psl Conjugation with CRM197, and Evaluation of Antigenicity in a QS-21/Pam3CSK4-Liposomal Formulation., PMID:40333663

Adjuvant Templating Improves On-Target/Off-Target Antibody Ratio Better than Linker Addition for M2-Derived Peptide Amphiphile Micelle Vaccines., PMID:40333333

Teclistamab Dosing in Responders: Modeling and Simulation Results from the MajesTEC-1 Study in Relapsed/Refractory Multiple Myeloma., PMID:40332715

Flow Cytometry-Based Rapid Assay for Antigen Specific Antibody Relative Affinity in SRBC-Immunized Mouse Models., PMID:40332147

[Research progress of peptide recognition-guided strategies for exosome isolation and enrichment]., PMID:40331609

Datasheet

Document Download

Anti-CS Polyclonal Antibody.pdf

 

$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CS Polyclonal Antibody [PHB18501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only